EKF Diagnostics Holdings plc
EKF.L · LSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | £0 | £0 | £0 | £0 |
| - Cash | £0 | £0 | £0 | £0 |
| + Debt | £0 | £0 | £0 | £0 |
| Enterprise Value | £0 | £0 | £0 | £0 |
| Revenue | £0 | £0 | £0 | £0 |
| % Growth | 1% | -0.9% | -2% | – |
| Gross Profit | £0 | £0 | £0 | £0 |
| % Margin | 50.2% | 49.4% | 47.8% | 48.2% |
| EBITDA | £0 | £0 | £0 | £0 |
| % Margin | 23.2% | 22.4% | 22% | 17.1% |
| Net Income | £0 | £0 | £0 | £0 |
| % Margin | 7.7% | 16.7% | 8.2% | 10.5% |
| EPS Diluted | 0.004 | 0.009 | 0.005 | 0.006 |
| % Growth | -53.3% | 100% | -23.3% | – |
| Operating Cash Flow | £0 | £0 | £0 | £0 |
| Capital Expenditures | -£0 | -£0 | -£0 | -£0 |
| Free Cash Flow | £0 | £0 | £0 | £0 |